These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17712614)

  • 1. The prevalence of live birth Down syndrome in the region of Primorsko-goranska County in Croatia, 1996-2005: the impact of screening and amniocentesis.
    Brajenović-Milić B; Prpić I; Petrović O; Ristić S; Brumini G; Kapović M
    Matern Child Health J; 2008 Sep; 12(5):620-3. PubMed ID: 17712614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
    Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
    Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in live birth prevalence of down syndrome in the Northern Netherlands 1987-96: the impact of screening and prenatal diagnosis.
    Wortelboer MJ; De Wolf BT; Verschuuren-Bemelmans CC; Reefhuis J; Mantingh A; Beekhuis JR; Cornel MC
    Prenat Diagn; 2000 Sep; 20(9):709-13. PubMed ID: 11015698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, prenatal screening and neonatal features in children with Down syndrome: a registry-based national study.
    Glivetic T; Rodin U; Milosevic M; Mayer D; Filipovic-Grcic B; Seferovic Saric M
    Ital J Pediatr; 2015 Oct; 41():81. PubMed ID: 26511759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of a Down syndrome live birth in women 45 years of age and older.
    Morris JK; De Vigan C; Mutton DE; Alberman E
    Prenat Diagn; 2005 Apr; 25(4):275-8. PubMed ID: 15849789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic counseling, prenatal screening and diagnosis of Down syndrome in the second trimester in women of advanced maternal age: a prospective study.
    Qi QW; Jiang YL; Zhou XY; Liu JT; Yin J; Bian XM
    Chin Med J (Engl); 2013; 126(11):2007-10. PubMed ID: 23769548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal testing for Down syndrome in the Jewish and non-Jewish populations in Israel.
    Davidov B; Goldman B; Akstein E; Barkai G; Legum C; Dar H; Romem Y; Amiel A; Cohen H; Bach G
    Isr J Med Sci; 1994 Aug; 30(8):629-33. PubMed ID: 8045747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimates of live birth prevalence of children with Down syndrome in the period 1991-2015 in the Netherlands.
    de Graaf G; Engelen JJM; Gijsbers ACJ; Hochstenbach R; Hoffer MJV; Kooper AJA; Sikkema-Raddatz B; Srebniak MI; van der Kevie-Kersemaekers AMF; van Zutven LJCM; Voorhoeve E
    J Intellect Disabil Res; 2017 May; 61(5):461-470. PubMed ID: 28261902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amniocentesis rate and the detection of Down syndrome and other chromosomal anomalies in Israel.
    Shohat M; Akstein E; Davidov B; Barkai G; Legum C; David M; Dar H; Romem Y; Amiel A; Cohen H
    Prenat Diagn; 1995 Oct; 15(10):967-70. PubMed ID: 8587865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
    Favre R; Duchange N; Vayssière C; Kohler M; Bouffard N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Moutel G
    Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Down's syndrome in a Scottish city.
    Lopez PM; Stone D; Gilmour H
    Paediatr Perinat Epidemiol; 1995 Jul; 9(3):331-40. PubMed ID: 7479281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down syndrome: interaction between culture, demography, and biology in determining the prevalence of a genetic trait.
    Olsen CL; Cross PK; Gensburg LJ
    Hum Biol; 2003 Aug; 75(4):503-20. PubMed ID: 14655874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of prenatal diagnosis, population ageing, and changing fertility rates on the live birth prevalence of Down syndrome in New York State, 1983-1992.
    Olsen CL; Cross PK; Gensburg LJ; Hughes JP
    Prenat Diagn; 1996 Nov; 16(11):991-1002. PubMed ID: 8953632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unchanged prevalence of Down syndrome in the Netherlands: results from an 11-year nationwide birth cohort.
    van Gameren-Oosterom HB; Buitendijk SE; Bilardo CM; van der Pal-de Bruin KM; Van Wouwe JP; Mohangoo AD
    Prenat Diagn; 2012 Nov; 32(11):1035-40. PubMed ID: 22865545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating Nationwide Prevalence of Live Births with Down Syndrome and Their Medical Expenditures in Korea.
    Park GW; Kim NE; Choi EK; Yang HJ; Won S; Lee YJ
    J Korean Med Sci; 2019 Aug; 34(31):e207. PubMed ID: 31392854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal genetic diagnosis and elective abortion in women over 35: utilization and relative impact on the birth prevalence of Down syndrome in Washington State.
    Luthy DA; Emanuel I; Hoehn H; Hall JG; Powers EK
    Am J Med Genet; 1980; 7(3):375-81. PubMed ID: 6451173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Down syndrome in Glasgow, 1980-96--the growing impact of prenatal diagnosis on younger mothers.
    Iliyasu Z; Gilmour WH; Stone DH
    Health Bull (Edinb); 2002 Jan; 60(1):20-6. PubMed ID: 12664764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.